Safety of intra-aortic balloon pump using glycoprotein IIb/IIIa antagonists

Keyphrases

• Intra-aortic Balloon Pump 100%
• Glycoprotein IIb/IIIa Inhibitors 100%
• Heparin 57%
• Primary Percutaneous Coronary Intervention 42%
• Thrombotic Complications 42%
• Anticoagulation 28%
• Limb Ischemia 28%
• Hemorrhagic Complications 28%
• Hospitalization 14%
• Treatment Duration 14%
• Consecutive Patients 14%
• Low Risk 14%
• Vascular Complications 14%
• Bleeding Risk 14%
• Cerebrovascular Accident 14%
• Thrombosis 14%
• Acute Myocardial Infarction 14%
• Bleeding Complications 14%
• Antagonist Treatment 14%
• Thrombotic Events 14%
• Major Bleeding 14%
• Embolization 14%
• Heparin Therapy 14%
• Post-primary 14%
• Minor Bleeding 14%
• Prolonged Resuscitation 14%
• Major Limb 14%

Medicine and Dentistry

• Intra-Aortic Balloon Pump 100%
• Fibrinogen Receptor Antagonist 100%
• Heparin 57%
• Primary Percutaneous Coronary Intervention 42%
• Anticoagulation 28%
• Limb Ischemia 28%
• Bleeding 14%
• Thrombosis 14%
• Acute Heart Infarction 14%
• Treatment Duration 14%
• Resuscitation 14%
• Embolization 14%
• Heparinization 14%